Welcome to P\S\L Group

Over 1 million visits a month
Click here to learn more

Doctors registered in 127 countries
Click here to learn more

FDA approves Amylin and Alkermes Bydureon - (Ref. The New York Times; CNBC; USA Today; FinanzNachrichten; MarketWatch; FNNO; NASDAQ; Bloomberg; Mass High Tech; Xconomy; TheStreet; FDA; Amylin) FDA approves Pfizer's Inlyta for advanced kidney cancer - (Ref. U.S. News & World; The Wall Street Journal; NASDAQ; The Baltimore Sun; The Washington Post; Bloomberg; FDA; Pfizer) Infinity halts Phase II trial of saridegib in pancreatic cancer, shares plunge 45 percent - (Ref. MarketWatch; Proactive Investors; The Wall Street Journal; Xconomy; CNBC; Business Wire) EU regulator ends probe into Servier's response to antitrust investigations - (Ref. Europa; BusinessWeek) Ranbaxy shares drop as analysts say FDA consent decree may affect generic versions of Actos, Nexium - (Ref. BusinessWeek; livemint.com; Bloomberg; Yahoo!News) More Industry News
Rapid Discontinuation of Prednisone After Kidney Transplantation Found Safe - (DGNews) FDA Approves Once-Weekly Treatment for Type 2 Diabetes - (DGNews) CD4 Levels Can Predict Laryngeal Cancer Treatment Response: Presented at MHNCS - (DGDispatch) Diagnostic Test Could Revolutionise Care of Patients With Gliomas - (DGNews) Researchers Suggest Patient-Centred Approach to Replacing ICDs - (DGNews) More Medical News
Privacy Policy \| All contents Copyright© 2012 P\S\L Group. All rights reserved.